10x Genomics, Inc. (TXG) Return on Equity (ROE) and Return on Assets (ROA)

10x Genomics, Inc. (TXG) return on equity (ROE) and return on assets (ROA) history. Calculate ROE/ROA in Excel with MarketXLS.

ROE & ROA Data

PeriodROEROA
2019-12-31-7.44%-5.16%
2020-12-31-73.43%-58.40%
2021-12-31-7.12%-5.71%
2022-12-31-20.60%-16.13%
2023-12-31-34.42%-26.43%
2024-12-31-25.72%-19.88%
2025-12-31-5.47%-4.18%

Return on equity divides net income by total shareholder equity at the period end. Return on assets divides the same net income by total assets at the period end. A figure reads N/A when the divisor is missing or not positive, because the ratio is not meaningful then.

How TXG compares with sector peers

SymbolCompanyReturn on equity (latest fiscal year)
NEOGNeogen Corporation-0.38%
RDNTRadNet Inc.-1.38%
TXMDTherapeuticsMD Inc.-2.12%
ATRCAtriCure Inc.-2.33%
FLGTFulgent Genetics Inc.-5.47%

These are five companies in the same sector as TXG with a comparable annual return on equity. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get 10x Genomics, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Return_on_Average_Equity("TXG", 2024)

BUY NOW